Successful management of massive intra-operative pulmonary embolism Apollo Hospitals
Acute Pulmonary Embolism has a high rate of mortality (26%) due to blockade of the pulmonary artery leading to acute increase in right ventricular pressure causing sudden cardiac decompensation. Lack of specific tests for early diagnosis is one of the causes for high rate of mortality but timely diagnosis and active intervention can save the life of the patient.
Cardiopulmonary Conditions Instructions(Must be included in pape.docxannandleola
Cardiopulmonary Conditions Instructions
(Must be included in paper and discussed in presentation)
1. What population is this condition typically found in?
2. How does the condition typically occur? What is the etiology?
3. What anatomical structures are involved?
4. What medical interventions are required?
5. What precautions or contraindications must the PTA be aware of during the patient’s medical treatment and/or during recovery?
6. What is the typical time frame for patient full recovery OR how long following medical intervention until the patient is considered able to return to full functional abilities (or return to PLOF).
7. What types of PT interventions are typically used to treat the condition during the:
a. acute phase
b. functional phase
8. Are there any recommended interventions that do not fall under the PTA’s scope of work?
9. Create an example daily treatment plan for the patient 3 weeks following injury/medical intervention based on information found during your research.
Running head: AN EXPLORE OF SARCOIDOSIS: MANAGING SARCOIDOSIS CONDITION
AN EXPLORE ON SARCOIDOSIS 2
AN EXPLORE ON SARCOIDOSIS
Student’s Name
Institutional Affiliation
An Explore on Sarcoidosis
Medical experts have discovered that sarcoidosis is a sequential ailment whose cause remains a mystery yet it presents varied and numerous forms of conditions, consequences, severity, and needs for medical attention especially treatments (Liu et al., 2014). Bearing in mind that sarcoidosis ailment associated with the development of tiny chains of inflammatory cells mainly in the lungs and lymph nodes as well as eyes and skin, the presentation of this condition could be typical or in many cases, they remain non-specific hence could mislead the diagnostic outcomes. The most significant case which could present this condition is the one with the forefront of pulmonary manifestations (Alicia, 2014). Consequently, the diagnosis depends on three common criteria which are not clinically common.
The Rates of Morbidity courtesy of Sarcoidosis
Scientific researches affiliated to the Sarcoidosis deaths in the States: 1999 to 2016 courtesy of the journal Respiratory Medicine explored that, America loses about 16,665 people through sarcoidosis. The data also revealed that the mortality rates had increased from 2.1 to 3 per 1 million persons in 1999 to 2016 respectively (Blankstein et al., 2014). These rates seemed to have increased from 2.1 to 3.1 from 1999 to 2002 and remained stable in the progressing years. The data also shows that patients within the age brackets of 35 years and above died courtesy of sarcoidosis with those between 65 to 75 years recording the highest rates of 8.5 deaths per 1 million while those between 75 to 84 years reporting nine deaths per 1 million (Liu et al., 2014). Either the rate of deaths among women patients increased by 32% (2.5 to 3.3 per 1 million patients while men morbidity increased by 73.3% (from 1.5 to 2.6 deat.
Clinical and haemodynamic evaluation of chronic thromboembolic pulmonary hype...Dra. Mônica Lapa
Avaliação clínica e hemodinâmica de doenças crônicas
pacientes com hipertensão pulmonar tromboembólica
agendada para tromboendarterectomia pulmonar.
A hipertensão da esquistossomose é um fator importante
fator de confusão?
Successful management of massive intra-operative pulmonary embolism Apollo Hospitals
Acute Pulmonary Embolism has a high rate of mortality (26%) due to blockade of the pulmonary artery leading to acute increase in right ventricular pressure causing sudden cardiac decompensation. Lack of specific tests for early diagnosis is one of the causes for high rate of mortality but timely diagnosis and active intervention can save the life of the patient.
Cardiopulmonary Conditions Instructions(Must be included in pape.docxannandleola
Cardiopulmonary Conditions Instructions
(Must be included in paper and discussed in presentation)
1. What population is this condition typically found in?
2. How does the condition typically occur? What is the etiology?
3. What anatomical structures are involved?
4. What medical interventions are required?
5. What precautions or contraindications must the PTA be aware of during the patient’s medical treatment and/or during recovery?
6. What is the typical time frame for patient full recovery OR how long following medical intervention until the patient is considered able to return to full functional abilities (or return to PLOF).
7. What types of PT interventions are typically used to treat the condition during the:
a. acute phase
b. functional phase
8. Are there any recommended interventions that do not fall under the PTA’s scope of work?
9. Create an example daily treatment plan for the patient 3 weeks following injury/medical intervention based on information found during your research.
Running head: AN EXPLORE OF SARCOIDOSIS: MANAGING SARCOIDOSIS CONDITION
AN EXPLORE ON SARCOIDOSIS 2
AN EXPLORE ON SARCOIDOSIS
Student’s Name
Institutional Affiliation
An Explore on Sarcoidosis
Medical experts have discovered that sarcoidosis is a sequential ailment whose cause remains a mystery yet it presents varied and numerous forms of conditions, consequences, severity, and needs for medical attention especially treatments (Liu et al., 2014). Bearing in mind that sarcoidosis ailment associated with the development of tiny chains of inflammatory cells mainly in the lungs and lymph nodes as well as eyes and skin, the presentation of this condition could be typical or in many cases, they remain non-specific hence could mislead the diagnostic outcomes. The most significant case which could present this condition is the one with the forefront of pulmonary manifestations (Alicia, 2014). Consequently, the diagnosis depends on three common criteria which are not clinically common.
The Rates of Morbidity courtesy of Sarcoidosis
Scientific researches affiliated to the Sarcoidosis deaths in the States: 1999 to 2016 courtesy of the journal Respiratory Medicine explored that, America loses about 16,665 people through sarcoidosis. The data also revealed that the mortality rates had increased from 2.1 to 3 per 1 million persons in 1999 to 2016 respectively (Blankstein et al., 2014). These rates seemed to have increased from 2.1 to 3.1 from 1999 to 2002 and remained stable in the progressing years. The data also shows that patients within the age brackets of 35 years and above died courtesy of sarcoidosis with those between 65 to 75 years recording the highest rates of 8.5 deaths per 1 million while those between 75 to 84 years reporting nine deaths per 1 million (Liu et al., 2014). Either the rate of deaths among women patients increased by 32% (2.5 to 3.3 per 1 million patients while men morbidity increased by 73.3% (from 1.5 to 2.6 deat.
Clinical and haemodynamic evaluation of chronic thromboembolic pulmonary hype...Dra. Mônica Lapa
Avaliação clínica e hemodinâmica de doenças crônicas
pacientes com hipertensão pulmonar tromboembólica
agendada para tromboendarterectomia pulmonar.
A hipertensão da esquistossomose é um fator importante
fator de confusão?
Introduction: There is growing evidence that Obstructive Sleep Apnea (OSA) is a risk factor for Pulmonary Embolism (PE). This
association represents a major public health burden.Aims and Objectives: To investigate Computed Tomography Obstruction Index (CTOI) and the Right Ventricular (RV) to Left Ventricular (LV) diameter ratio with OSA severity. Materials and Methods: 46 Patients with (PE) were evaluated for OSA. Pulmonary Artery Obstruction Index (PAOI) and RV/ LV diameter ratio was measured by pulmonary angiography. Pulmonary Embolism Severity Index (PESI) was determined. Epworth Sleepiness Scale (ESS) and Polysomnography (PSG) was performed for all patients. Based on the PAOI, patients divided into (< 15%, 15-50%, > 50%).
Elevated Tissue Doppler E/E' on Index Admission Can Help Identify Patients at...crimsonpublishersOJCHD
Readmissions for congestive Heart Failure (CHF) are a major healthcare problem that contributes significantly to the overall healthcare expenditure. About 24% of patients are readmitted to the hospital within 30 days of discharge. We investigated whether a non-invasive estimate of left atrial filling pressure, an elevated ratio of early trans mitral flow velocity to early diastolic mitral annular velocity (E/E'), during the index admission for CHF could independently predict 30 day readmission.
Predictors of weaning from mechanical ventilator outcomeMuhammad Asim Rana
This is a very useful presentation for respiratory therapists and ICU and Emergency physicians. Intended to teach how to assess you patient's readiness for weaning from mechanical ventilator and successful separation from machine.
Critical Illness Polyneuromyopathy (CIPNM) is frequently present in critically ill as a certain degree of symmetric extremity paresis and respiratory muscle weakness. The consequences of this complication may last for months or years after severe illness. It prolongs the stay in ICU and dependence onmechanical ventilation, increases long-term disability and care costs. We report a 58-year old female patient admitted to our Intensive Care Unit for acute respiratory insuffi ciency due to infl uenza pneumonia and acute respiratory distress syndrome. Thirty-three days of mechanical ventilation and 11 days of extracorporal membrane oxygenation were complicated by severe CIPNM, tetraparesis, mental disorders, and diffi culties in weaning off mechanical ventilation. No specifi c therapy is available for treatment of CIPNM. Preventive, supportive and rehabilitation measures are discussed in the article.
Clinical Outcomes of Intensive Inpatient Blood Pressure.pdfSHINTU5
OBJECTIVE To examine the association of intensive treatment of elevated inpatient BPs
with in-hospital clinical outcomes of older adults hospitalized for noncardiac conditions.
DESIGN, SETTING, AND PARTICIPANTS This retrospective cohort study examined Veterans
Health Administration data between October 1, 2015, and December 31, 2017, for patients
aged 65 years or older hospitalized for noncardiovascular diagnoses and who experienced
elevated BPs in the first 48 hours of hospitalization.
INTERVENTIONS Intensive BP treatment following the first 48 hours of hospitalization,
defined as receipt of intravenous antihypertensives or oral classes not used prior to
admission.
MAIN OUTCOME AND MEASURES The primary outcomewas a composite of inpatient mortality,
intensive care unit transfer, stroke, acute kidney injury, B-type natriuretic peptide elevation,
and troponin elevation. Data were analyzed between October 1, 2021, and January 10, 2023,
with propensity score overlap weighting used to adjust for confounding between those who
did and did not receive early intensive treatment.
RESULTS Among 66 140 included patients (mean [SD] age, 74.4 [8.1] years; 97.5%male
and 2.6%female; 17.4%Black, 1.7%Hispanic, and 75.9%White), 14 084 (21.3%) received
intensive BP treatment in the first 48 hours of hospitalization. Patients who received early
intensive treatment vs those who did not continued to receive a greater number of additional
antihypertensives during the remainder of their hospitalization (mean additional doses, 6.1
[95%CI, 5.8-6.4] vs 1.6 [95%CI, 1.5-1.8], respectively). Intensive treatment was associated
with a greater risk of the primary composite outcome (1220 [8.7%] vs 3570 [6.9%]; weighted
odds ratio [OR], 1.28; 95%CI, 1.18-1.39), with the highest risk among patients receiving
intravenous antihypertensives (weighted OR, 1.90; 95%CI, 1.65-2.19). Intensively treated
patients were more likely to experience each component of the composite outcome except
for stroke and mortality. Findings were consistent across subgroups stratified by age, frailty,
preadmission BP, early hospitalization BP, and cardiovascular disease history.
CONCLUSIONS AND RELEVANCE The study’s findings indicate that among hospitalized
older adults with elevated BPs, intensive pharmacologic antihypertensive treatment
was associated with a greater risk of adverse events. These findings do not support
the treatment of elevated inpatient BPs without evidence of end organ damage,
and they highlight the need for randomized clinical trials of inpatient BP treatment targets
respiratory inspections are common in elderly people and often times,that tickles into the lungs.More often than not they have comorbiidites,like Diabetes,hypertension etc.Hence,the treatment has to be different and some times the prognosis is guarded
Introduction: There is growing evidence that Obstructive Sleep Apnea (OSA) is a risk factor for Pulmonary Embolism (PE). This
association represents a major public health burden.Aims and Objectives: To investigate Computed Tomography Obstruction Index (CTOI) and the Right Ventricular (RV) to Left Ventricular (LV) diameter ratio with OSA severity. Materials and Methods: 46 Patients with (PE) were evaluated for OSA. Pulmonary Artery Obstruction Index (PAOI) and RV/ LV diameter ratio was measured by pulmonary angiography. Pulmonary Embolism Severity Index (PESI) was determined. Epworth Sleepiness Scale (ESS) and Polysomnography (PSG) was performed for all patients. Based on the PAOI, patients divided into (< 15%, 15-50%, > 50%).
Elevated Tissue Doppler E/E' on Index Admission Can Help Identify Patients at...crimsonpublishersOJCHD
Readmissions for congestive Heart Failure (CHF) are a major healthcare problem that contributes significantly to the overall healthcare expenditure. About 24% of patients are readmitted to the hospital within 30 days of discharge. We investigated whether a non-invasive estimate of left atrial filling pressure, an elevated ratio of early trans mitral flow velocity to early diastolic mitral annular velocity (E/E'), during the index admission for CHF could independently predict 30 day readmission.
Predictors of weaning from mechanical ventilator outcomeMuhammad Asim Rana
This is a very useful presentation for respiratory therapists and ICU and Emergency physicians. Intended to teach how to assess you patient's readiness for weaning from mechanical ventilator and successful separation from machine.
Critical Illness Polyneuromyopathy (CIPNM) is frequently present in critically ill as a certain degree of symmetric extremity paresis and respiratory muscle weakness. The consequences of this complication may last for months or years after severe illness. It prolongs the stay in ICU and dependence onmechanical ventilation, increases long-term disability and care costs. We report a 58-year old female patient admitted to our Intensive Care Unit for acute respiratory insuffi ciency due to infl uenza pneumonia and acute respiratory distress syndrome. Thirty-three days of mechanical ventilation and 11 days of extracorporal membrane oxygenation were complicated by severe CIPNM, tetraparesis, mental disorders, and diffi culties in weaning off mechanical ventilation. No specifi c therapy is available for treatment of CIPNM. Preventive, supportive and rehabilitation measures are discussed in the article.
Clinical Outcomes of Intensive Inpatient Blood Pressure.pdfSHINTU5
OBJECTIVE To examine the association of intensive treatment of elevated inpatient BPs
with in-hospital clinical outcomes of older adults hospitalized for noncardiac conditions.
DESIGN, SETTING, AND PARTICIPANTS This retrospective cohort study examined Veterans
Health Administration data between October 1, 2015, and December 31, 2017, for patients
aged 65 years or older hospitalized for noncardiovascular diagnoses and who experienced
elevated BPs in the first 48 hours of hospitalization.
INTERVENTIONS Intensive BP treatment following the first 48 hours of hospitalization,
defined as receipt of intravenous antihypertensives or oral classes not used prior to
admission.
MAIN OUTCOME AND MEASURES The primary outcomewas a composite of inpatient mortality,
intensive care unit transfer, stroke, acute kidney injury, B-type natriuretic peptide elevation,
and troponin elevation. Data were analyzed between October 1, 2021, and January 10, 2023,
with propensity score overlap weighting used to adjust for confounding between those who
did and did not receive early intensive treatment.
RESULTS Among 66 140 included patients (mean [SD] age, 74.4 [8.1] years; 97.5%male
and 2.6%female; 17.4%Black, 1.7%Hispanic, and 75.9%White), 14 084 (21.3%) received
intensive BP treatment in the first 48 hours of hospitalization. Patients who received early
intensive treatment vs those who did not continued to receive a greater number of additional
antihypertensives during the remainder of their hospitalization (mean additional doses, 6.1
[95%CI, 5.8-6.4] vs 1.6 [95%CI, 1.5-1.8], respectively). Intensive treatment was associated
with a greater risk of the primary composite outcome (1220 [8.7%] vs 3570 [6.9%]; weighted
odds ratio [OR], 1.28; 95%CI, 1.18-1.39), with the highest risk among patients receiving
intravenous antihypertensives (weighted OR, 1.90; 95%CI, 1.65-2.19). Intensively treated
patients were more likely to experience each component of the composite outcome except
for stroke and mortality. Findings were consistent across subgroups stratified by age, frailty,
preadmission BP, early hospitalization BP, and cardiovascular disease history.
CONCLUSIONS AND RELEVANCE The study’s findings indicate that among hospitalized
older adults with elevated BPs, intensive pharmacologic antihypertensive treatment
was associated with a greater risk of adverse events. These findings do not support
the treatment of elevated inpatient BPs without evidence of end organ damage,
and they highlight the need for randomized clinical trials of inpatient BP treatment targets
respiratory inspections are common in elderly people and often times,that tickles into the lungs.More often than not they have comorbiidites,like Diabetes,hypertension etc.Hence,the treatment has to be different and some times the prognosis is guarded
Report Back from SGO 2024: What’s the Latest in Cervical Cancer?bkling
Are you curious about what’s new in cervical cancer research or unsure what the findings mean? Join Dr. Emily Ko, a gynecologic oncologist at Penn Medicine, to learn about the latest updates from the Society of Gynecologic Oncology (SGO) 2024 Annual Meeting on Women’s Cancer. Dr. Ko will discuss what the research presented at the conference means for you and answer your questions about the new developments.
Title: Sense of Taste
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the structure and function of taste buds.
Describe the relationship between the taste threshold and taste index of common substances.
Explain the chemical basis and signal transduction of taste perception for each type of primary taste sensation.
Recognize different abnormalities of taste perception and their causes.
Key Topics:
Significance of Taste Sensation:
Differentiation between pleasant and harmful food
Influence on behavior
Selection of food based on metabolic needs
Receptors of Taste:
Taste buds on the tongue
Influence of sense of smell, texture of food, and pain stimulation (e.g., by pepper)
Primary and Secondary Taste Sensations:
Primary taste sensations: Sweet, Sour, Salty, Bitter, Umami
Chemical basis and signal transduction mechanisms for each taste
Taste Threshold and Index:
Taste threshold values for Sweet (sucrose), Salty (NaCl), Sour (HCl), and Bitter (Quinine)
Taste index relationship: Inversely proportional to taste threshold
Taste Blindness:
Inability to taste certain substances, particularly thiourea compounds
Example: Phenylthiocarbamide
Structure and Function of Taste Buds:
Composition: Epithelial cells, Sustentacular/Supporting cells, Taste cells, Basal cells
Features: Taste pores, Taste hairs/microvilli, and Taste nerve fibers
Location of Taste Buds:
Found in papillae of the tongue (Fungiform, Circumvallate, Foliate)
Also present on the palate, tonsillar pillars, epiglottis, and proximal esophagus
Mechanism of Taste Stimulation:
Interaction of taste substances with receptors on microvilli
Signal transduction pathways for Umami, Sweet, Bitter, Sour, and Salty tastes
Taste Sensitivity and Adaptation:
Decrease in sensitivity with age
Rapid adaptation of taste sensation
Role of Saliva in Taste:
Dissolution of tastants to reach receptors
Washing away the stimulus
Taste Preferences and Aversions:
Mechanisms behind taste preference and aversion
Influence of receptors and neural pathways
Impact of Sensory Nerve Damage:
Degeneration of taste buds if the sensory nerve fiber is cut
Abnormalities of Taste Detection:
Conditions: Ageusia, Hypogeusia, Dysgeusia (parageusia)
Causes: Nerve damage, neurological disorders, infections, poor oral hygiene, adverse drug effects, deficiencies, aging, tobacco use, altered neurotransmitter levels
Neurotransmitters and Taste Threshold:
Effects of serotonin (5-HT) and norepinephrine (NE) on taste sensitivity
Supertasters:
25% of the population with heightened sensitivity to taste, especially bitterness
Increased number of fungiform papillae
Title: Sense of Smell
Presenter: Dr. Faiza, Assistant Professor of Physiology
Qualifications:
MBBS (Best Graduate, AIMC Lahore)
FCPS Physiology
ICMT, CHPE, DHPE (STMU)
MPH (GC University, Faisalabad)
MBA (Virtual University of Pakistan)
Learning Objectives:
Describe the primary categories of smells and the concept of odor blindness.
Explain the structure and location of the olfactory membrane and mucosa, including the types and roles of cells involved in olfaction.
Describe the pathway and mechanisms of olfactory signal transmission from the olfactory receptors to the brain.
Illustrate the biochemical cascade triggered by odorant binding to olfactory receptors, including the role of G-proteins and second messengers in generating an action potential.
Identify different types of olfactory disorders such as anosmia, hyposmia, hyperosmia, and dysosmia, including their potential causes.
Key Topics:
Olfactory Genes:
3% of the human genome accounts for olfactory genes.
400 genes for odorant receptors.
Olfactory Membrane:
Located in the superior part of the nasal cavity.
Medially: Folds downward along the superior septum.
Laterally: Folds over the superior turbinate and upper surface of the middle turbinate.
Total surface area: 5-10 square centimeters.
Olfactory Mucosa:
Olfactory Cells: Bipolar nerve cells derived from the CNS (100 million), with 4-25 olfactory cilia per cell.
Sustentacular Cells: Produce mucus and maintain ionic and molecular environment.
Basal Cells: Replace worn-out olfactory cells with an average lifespan of 1-2 months.
Bowman’s Gland: Secretes mucus.
Stimulation of Olfactory Cells:
Odorant dissolves in mucus and attaches to receptors on olfactory cilia.
Involves a cascade effect through G-proteins and second messengers, leading to depolarization and action potential generation in the olfactory nerve.
Quality of a Good Odorant:
Small (3-20 Carbon atoms), volatile, water-soluble, and lipid-soluble.
Facilitated by odorant-binding proteins in mucus.
Membrane Potential and Action Potential:
Resting membrane potential: -55mV.
Action potential frequency in the olfactory nerve increases with odorant strength.
Adaptation Towards the Sense of Smell:
Rapid adaptation within the first second, with further slow adaptation.
Psychological adaptation greater than receptor adaptation, involving feedback inhibition from the central nervous system.
Primary Sensations of Smell:
Camphoraceous, Musky, Floral, Pepperminty, Ethereal, Pungent, Putrid.
Odor Detection Threshold:
Examples: Hydrogen sulfide (0.0005 ppm), Methyl-mercaptan (0.002 ppm).
Some toxic substances are odorless at lethal concentrations.
Characteristics of Smell:
Odor blindness for single substances due to lack of appropriate receptor protein.
Behavioral and emotional influences of smell.
Transmission of Olfactory Signals:
From olfactory cells to glomeruli in the olfactory bulb, involving lateral inhibition.
Primitive, less old, and new olfactory systems with different path
New Directions in Targeted Therapeutic Approaches for Older Adults With Mantl...i3 Health
i3 Health is pleased to make the speaker slides from this activity available for use as a non-accredited self-study or teaching resource.
This slide deck presented by Dr. Kami Maddocks, Professor-Clinical in the Division of Hematology and
Associate Division Director for Ambulatory Operations
The Ohio State University Comprehensive Cancer Center, will provide insight into new directions in targeted therapeutic approaches for older adults with mantle cell lymphoma.
STATEMENT OF NEED
Mantle cell lymphoma (MCL) is a rare, aggressive B-cell non-Hodgkin lymphoma (NHL) accounting for 5% to 7% of all lymphomas. Its prognosis ranges from indolent disease that does not require treatment for years to very aggressive disease, which is associated with poor survival (Silkenstedt et al, 2021). Typically, MCL is diagnosed at advanced stage and in older patients who cannot tolerate intensive therapy (NCCN, 2022). Although recent advances have slightly increased remission rates, recurrence and relapse remain very common, leading to a median overall survival between 3 and 6 years (LLS, 2021). Though there are several effective options, progress is still needed towards establishing an accepted frontline approach for MCL (Castellino et al, 2022). Treatment selection and management of MCL are complicated by the heterogeneity of prognosis, advanced age and comorbidities of patients, and lack of an established standard approach for treatment, making it vital that clinicians be familiar with the latest research and advances in this area. In this activity chaired by Michael Wang, MD, Professor in the Department of Lymphoma & Myeloma at MD Anderson Cancer Center, expert faculty will discuss prognostic factors informing treatment, the promising results of recent trials in new therapeutic approaches, and the implications of treatment resistance in therapeutic selection for MCL.
Target Audience
Hematology/oncology fellows, attending faculty, and other health care professionals involved in the treatment of patients with mantle cell lymphoma (MCL).
Learning Objectives
1.) Identify clinical and biological prognostic factors that can guide treatment decision making for older adults with MCL
2.) Evaluate emerging data on targeted therapeutic approaches for treatment-naive and relapsed/refractory MCL and their applicability to older adults
3.) Assess mechanisms of resistance to targeted therapies for MCL and their implications for treatment selection
Couples presenting to the infertility clinic- Do they really have infertility...Sujoy Dasgupta
Dr Sujoy Dasgupta presented the study on "Couples presenting to the infertility clinic- Do they really have infertility? – The unexplored stories of non-consummation" in the 13th Congress of the Asia Pacific Initiative on Reproduction (ASPIRE 2024) at Manila on 24 May, 2024.
Prix Galien International 2024 Forum ProgramLevi Shapiro
June 20, 2024, Prix Galien International and Jerusalem Ethics Forum in ROME. Detailed agenda including panels:
- ADVANCES IN CARDIOLOGY: A NEW PARADIGM IS COMING
- WOMEN’S HEALTH: FERTILITY PRESERVATION
- WHAT’S NEW IN THE TREATMENT OF INFECTIOUS,
ONCOLOGICAL AND INFLAMMATORY SKIN DISEASES?
- ARTIFICIAL INTELLIGENCE AND ETHICS
- GENE THERAPY
- BEYOND BORDERS: GLOBAL INITIATIVES FOR DEMOCRATIZING LIFE SCIENCE TECHNOLOGIES AND PROMOTING ACCESS TO HEALTHCARE
- ETHICAL CHALLENGES IN LIFE SCIENCES
- Prix Galien International Awards Ceremony
ARTIFICIAL INTELLIGENCE IN HEALTHCARE.pdfAnujkumaranit
Artificial intelligence (AI) refers to the simulation of human intelligence processes by machines, especially computer systems. It encompasses tasks such as learning, reasoning, problem-solving, perception, and language understanding. AI technologies are revolutionizing various fields, from healthcare to finance, by enabling machines to perform tasks that typically require human intelligence.
Tom Selleck Health: A Comprehensive Look at the Iconic Actor’s Wellness Journeygreendigital
Tom Selleck, an enduring figure in Hollywood. has captivated audiences for decades with his rugged charm, iconic moustache. and memorable roles in television and film. From his breakout role as Thomas Magnum in Magnum P.I. to his current portrayal of Frank Reagan in Blue Bloods. Selleck's career has spanned over 50 years. But beyond his professional achievements. fans have often been curious about Tom Selleck Health. especially as he has aged in the public eye.
Follow us on: Pinterest
Introduction
Many have been interested in Tom Selleck health. not only because of his enduring presence on screen but also because of the challenges. and lifestyle choices he has faced and made over the years. This article delves into the various aspects of Tom Selleck health. exploring his fitness regimen, diet, mental health. and the challenges he has encountered as he ages. We'll look at how he maintains his well-being. the health issues he has faced, and his approach to ageing .
Early Life and Career
Childhood and Athletic Beginnings
Tom Selleck was born on January 29, 1945, in Detroit, Michigan, and grew up in Sherman Oaks, California. From an early age, he was involved in sports, particularly basketball. which played a significant role in his physical development. His athletic pursuits continued into college. where he attended the University of Southern California (USC) on a basketball scholarship. This early involvement in sports laid a strong foundation for his physical health and disciplined lifestyle.
Transition to Acting
Selleck's transition from an athlete to an actor came with its physical demands. His first significant role in "Magnum P.I." required him to perform various stunts and maintain a fit appearance. This role, which he played from 1980 to 1988. necessitated a rigorous fitness routine to meet the show's demands. setting the stage for his long-term commitment to health and wellness.
Fitness Regimen
Workout Routine
Tom Selleck health and fitness regimen has evolved. adapting to his changing roles and age. During his "Magnum, P.I." days. Selleck's workouts were intense and focused on building and maintaining muscle mass. His routine included weightlifting, cardiovascular exercises. and specific training for the stunts he performed on the show.
Selleck adjusted his fitness routine as he aged to suit his body's needs. Today, his workouts focus on maintaining flexibility, strength, and cardiovascular health. He incorporates low-impact exercises such as swimming, walking, and light weightlifting. This balanced approach helps him stay fit without putting undue strain on his joints and muscles.
Importance of Flexibility and Mobility
In recent years, Selleck has emphasized the importance of flexibility and mobility in his fitness regimen. Understanding the natural decline in muscle mass and joint flexibility with age. he includes stretching and yoga in his routine. These practices help prevent injuries, improve posture, and maintain mobilit
Ozempic: Preoperative Management of Patients on GLP-1 Receptor Agonists Saeid Safari
Preoperative Management of Patients on GLP-1 Receptor Agonists like Ozempic and Semiglutide
ASA GUIDELINE
NYSORA Guideline
2 Case Reports of Gastric Ultrasound
- Video recording of this lecture in English language: https://youtu.be/lK81BzxMqdo
- Video recording of this lecture in Arabic language: https://youtu.be/Ve4P0COk9OI
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
Hemodialysis: Chapter 3, Dialysis Water Unit - Dr.Gawad
Predictors of prolonged hospital stay in patients with Acute pulmonary thromboembolism
1. Predictors of Prolonged Hospital Stay in Patients with
Acute
Pulmonary Thromboembolism
(A Hospital Based Cohort Study)
Presentor- Dr.Tapas Tripathi
Modarator- Dr. Rashika Sah
Journal of The Association of Physicians of India May 2022
2. Introduction
Pulmonary thromboembolism (PTE) is a relatively common and potentially fatal
medical emergency.
It is the third most common cardiovascular disease after acute coronary syndrome
and stroke, with an incidence rate of 112 cases per 100,000 in the general population.
PTE is associated with a wide variety of presenting features, ranging from no
symptoms to sudden death.
Most Patients with PTE are admitted to hospital for their initial treatment.
Several factors are believed to influence length of hospital stay in pulmonary embolism
patients, including patient demographics, clinical characteristics, physician resistance,
difficulty in risk stratification, and the type of anticoagulation received.
3. However, no validated predictive models are available to estimate the
length of hospital stay in pulmonary embolism patients.
There is very scarce data from the developing countries regarding
pulmonary embolism associated hospitalisations and the factors affecting
the length of hospital stay.
The aim of this study was to identify factors that are associated with
prolonged hospital stay in patients admitted due to pulmonary embolism.
4. Materials and Methods
It was a hospital based observational prospective study, conducted at a
leading tertiary care institute in north India.
Patients were included only if they had confirmed diagnosis of pulmonary
embolism by CT pulmonary angiography.
Patients with a history of pulmonary embolism prior to present
hospitalisation were excluded from the study.
The in-patient medical records of all the included patients were reviewed
and the length of hospital stay was calculated for each eligible patient.
Hospital stay was calculated from the date of admission to the date of
discharge or death.
5. Based on the PESI score, patients were classified into five different
classes: Class I: PESI Score of ≤65 points, Class II-;66–85 points, Class III:
86–105 points, Class IV: 106–125 point and Class V: >125points.
Mean length of hospital stay was calculated for this cohort of patients
and patients were later stratified into two cohorts: Shorter Hospital stay
(less than mean i.e., < 10 Days);
Prolonged Hospital stay (longer than mean i.e., ≥10 Days). t-test was
employed for comparing continuous variables between the two cohorts.
Chi-square test or Fisher’s exact test, whichever appropriate, was applied
for comparing categorical variables.
6.
7. Results
A total of 150 patients were enrolled during the 4-year study period. Mean
hospital stay for these patients was 10 days.
67 patients (44.67%) had shorter hospital duration (less than mean duration of
10 days) and 83 patients (55.33%) had prolonged hospital stay (≥10 days).
Male sex and rural background of patients did not predict prolonged hospital
stay.
The most common underlying risk factors in our patients with pulmonary
thromboembolism were immobilization (defined as bed rest for more than 3
days), chronic lung disease, malignancy, history of trauma to lower extremity
and pelvis within preceding three months, recent surgery and previous history
of stroke.
8. Tachycardia (defined as heart rate of 100 per minute or more), tachypnea
(defined as respiratory rate of 20 per minute or greater), hypotension
(defined as blood pressure of less than 90/60 mm Hg for more than 15
minutes) and decreased level of consciousness (defined as Glassgow Coma
Scale score of less than 15) at presentation were found to be significantly
more prevalent in the cohort of patients with prolonged hospital stay.
Different lab parameters were compared in the two cohorts of patients
and it was found that total leucocyte count (TLC) of greater than
11,000/ul, spo2 less than 90%, and pCo2 of less than 30 mm Hg were
more common in patients with prolonged stay. elevated troponin levels
(measured qualitatively by rapid card tests) were significantly more
common in patients with prolonged hospital stay.
9. Among the ECG findings, presence of sinus tachycardia, S1Q3T3, Rightaxis
deviation (RAD) and right bundle branch block (RBBB) were significantlyassociated
with prolonged hospital stay.
Similarly, presence of dilated RA/ RV, RV hypokinesia and pulmonary hypertension
(PAH) were more likely present in prolonged hospital stay.
Mean d dimer was calculated for the patients with shorter hospital stay and
prolonged hospital stay.
The difference between the two cohorts was not statistically significant. Use of
thrombolytic agents and presence of complications were associated
withprolonged hospital stay.
10.
11. The mean duration of hospital stay varied significantly with the PESI class,
with patients belonging to class I having a mean stay of 6.9 days (SD=5.78
days) and patients belonging to class V having a mean of 17.1 days (SD=6.13
days)
150 patients were included in the study with 67 patients (44.67%) having
shorter hospital stay (<10 days) and 83 patients (55.33%) having
prolongedhospital stay (≥10 days). On multivariate regression analysis,
parameters that were found to be statistically significant were hypotension
at presentation, decreased level of consciousness, pco2 < 30 mmHg,
presence of S1Q3T3 pattern on electrocardiogram (ECG) and high risk PESI
(class III-V).
12.
13.
14. Disscusion
Our study shows that hemodynamic instability and decreased level of
consciousness at presentation is associated with prolonged hospital stay in
patients with pulmonary embolism.
Our study shows that the proportion of patients with an elevated leucocyte
counts, pco2 less than 30, spo2 less than 90% and elevated cardiac
troponins was significantly higher in patient cohort with prolonged hospital
stay.
Presence of low Pco2 independently predicted a prolonged hospital stay.
Though the exact reason for this observation could not be ascertained, it
could be partly because of increased respiratory distress in these patients
with subsequent prolonged observation period.
15. Our study shows that the proportionof patients with an elevated
leucocyte counts, pco2 less than 30, spo2 less than 90% and elevated
cardiac troponins was significantly higher in patient cohort with prolonged
hospital stay.
Presence of low Pco2 independently predicted a prolonged hospital stay.
ECG signs that are reported as good predictors of a negative outcome
included S1Q3T3, complete right bundle branch block, T-wave inversion,
right axis deviation, and atrial fibrillation.
We found in our study that S1Q3T3, Right axis deviation and right bundle
branch was significantly present more in patients with a prolonged
hospital stay than patients with a shorter hospital stay.
16. PESI) is the most extensively validated tool devised to predict mortality in
patients with PE and identify low risk patients who may be candidates for
outpatient treatment.
We aimed to analyse the usefulness of PESI score and PESI class in
predicting the duration of hospital stay in patients with pulmonary
embolism.
Our study found that higher the PESI class, more is the duration of hospital
stay. Also, a PESI score of >95 points predicted a prolonged hospital stay
with a sensitivity of 81.9% and a specificity of 50%.
17. Limitations
There are certain limitations inour study. First, the healthcare setup in which
study was conducted is not universal and the results can’t be generalised.
Secondly, attitude oftreating physicians varies widely with regards to ideal
time to discharge the patients with pulmonary thromboembolism and this
could be one confounding factor.
Finally, many patients had delay in discharge because of use of
conventional oral anticoagulants, but we had no data regarding the delay
caused by getting INR in the therapeutic range.
18. Conclusion
PESI class can be effectively used to predict prolonged hospital stay in
patients with pulmonary embolism. Patients with hypotension at
presentation, decreased level of consciousness, pco2 less than 30 mmHg,
and S1Q3T3 on ECG are more likely to have prolonged hospital stay in our
healthcare setup.
The findings from this study may help clinicians to take decision
prospectively about duration of hospital stay for effective health care
utilisation in patients with pulmonary embolism.
19. TAKE HOME MESSAGE
Patients with severe pulmonary embolism
(hypotension at presentation, decreased level of
consciousness, pco2 less than 30 mmHg, and
S1Q3T3 on ECG) are more likely to have
prolonged hospital stay.